Cite
HARVARD Citation
Lamers-Karnebeek, F. et al. (2019). Adalimumab drug and antidrug antibody levels do not predict flare risk after stopping adalimumab in RA patients with low disease activity. Rheumatology. pp. 427-431. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lamers-Karnebeek, F. et al. (2019). Adalimumab drug and antidrug antibody levels do not predict flare risk after stopping adalimumab in RA patients with low disease activity. Rheumatology. pp. 427-431. [Online].